About Aortica Corp
Aortica Corp is a company based in Bellevue (United States) founded in 2014 was acquired by Terumo Medical in November 2019. Aortica Corp has raised $7 million across 1 funding round from investors including Terumo Medical. The company has 2 employees as of December 31, 2022. Aortica Corp operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
- Headquarter Bellevue, United States
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Aortica Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7 M (USD)
in 1 rounds
-
Latest Funding Round
$7 M (USD), Series A
Nov 24, 2014
- Investors
-
Employee Count
2
as on Dec 31, 2022
-
Acquired by
Terumo Medical
(Nov 20, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aortica Corp
Aortica Corp has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Series A round of $7 million completed in November 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aortica Corp
Aortica Corp has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Terumo Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Portfolio of medical devices for interventional cardiology is provided.
|
Locked | Locked | Locked |
Investor details for Aortica Corp
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aortica Corp
Investment portfolio details for Aortica Corp
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aortica Corp
Detailed financials for Aortica Corp
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aortica Corp Comparisons
Peer comparison for Aortica Corp
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aortica Corp
Aortica Corp operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| Locked | Locked | Locked |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| Locked | Locked | Locked |
Designs and manufactures for endovascular aortic repair equipment
|
|
| Locked | Locked | Locked |
Endovascular devices for aortic aneurysms are developed.
|
|
| Locked | Locked | Locked |
Endograft anchoring systems for aortic aneurysms are developed.
|
|
| Locked | Locked | Locked |
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
|
Detailed competitors of Aortica Corp
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aortica Corp
Complete news archive for Aortica Corp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aortica Corp
Aortica Corp was founded in 2014.
Aortica Corp is headquartered in Bellevue, United States. It is registered at Bellevue, Washington, United States.
Aortica Corp is a funded company, having raised a total of $7M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Aortica Corp is 2.
Aortica Corporation was founded in 2014 and is headquartered in Bellevue, United States. Technology is developed to address abdominal aortic aneurysm disease through endovascular methods. Stent grafts are delivered via catheter insertion into the aorta, supported by 3D medical printing processes. Operations center on cardiovascular medical devices, with a focus on procedural tools for physicians in the healthcare sector.
Aortica Corp's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Aortica Corp has 1 investor. Key investors include Terumo Medical.